| EZ SPERSE DEXCEL PHARMA TECHNOLOGIES LTD.
AN ISRAELI COMPANY
1751380 21 Oct 2015 | on 31 Oct 2017 | Class 005 Class 005 Pharmaceutical Products Orally disintegrating tablets and orally disintegrating medicaments for the treatment of cardiovascular, endocrine namely hypergastrinemia and zollinger-ellison syndrome, gastrointestinal, biliary, allergic, infectious namely bacterial infections caused by helicobacter pylori, inflammatory namely inflammation of gastro-intestine tract of any origin, menopausal, nutritional namely obesity, anemia, scurvy, mineral and vitamin deficiency and malnutrition, metabolic namely any pathologic hypersecretory conditions, diabetes, autoimmune, connective tissue, ophthalmologic, respiratory, urogenital, urological, erectile dysfunction, sexual dysfunction, gynecology, obstetric, pediatric, hematologic, oncological and fungal diseases and disorders | |